Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity against Hepatocellular Carcinoma Both In Vitro and In Vivo Independently of Phosphodiesterase Inhibition

Open Access

Peer-reviewed

Research Article

Liping Sun,

Affiliation Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
⨯
Haitian Quan,

Affiliation Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
⨯
Chengying Xie,

Affiliation Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
⨯
Lei Wang,

Affiliation Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
⨯
Youhong Hu,

Affiliation Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
⨯
Liguang Lou

* E-mail: lglou@mail.shcnc.ac.cn

Affiliation Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
⨯

Reader Comments (0)

Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Cyclins
Is the Subject Area "Cyclins" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cell cycle and cell division
Is the Subject Area "Cell cycle and cell division" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Cell proliferation
Is the Subject Area "Cell proliferation" applicable to this article?

Thanks for your feedback.